The Rx for High-Performance Leadership: Cutting Through the Chaos
In a turbulent era for biopharma, leadership demands clarity, resilience, and adaptability. In this candid podcast conversation with Pharm Exec, Ken Banta, founder and CEO of The Vanguard Network, shares high-level insights on what CEOs can do to thrive amid the disruption—from regulatory agility to cultural resilience. The corporate strategy expert explains why the best leaders are the best learners—and how prioritization, honesty, and boldness will separate those who merely survive from those who shape the industry’s future.
--------
14:39
--------
14:39
Pharmaceutical Executive Weekly:CSL Cuts Jobs, Pfizer’s Sickle Cell Setback, and Eli Lilly Expands Zepbound Access
In this week’s Pharmaceutical Executive Weekly, we cover CSL’s decision to cut 15% of its U.S. workforce and close 22 plasma centers, Pfizer’s Phase 3 trial failure in sickle cell disease, and Eli Lilly’s new LillyDirect program expanding full-dose Zepbound access for obesity patients.
--------
2:08
--------
2:08
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, discusses strategies to address underrepresentation in phase III psoriasis trials. She also talks about Takeda's partnerships with community stakeholders like Inside Edge, Black Health Matters, and Hispanic Communication Global Network to help improve engagement, address operational barriers by incorporating multicultural imagery, and prioritize sites with diverse patient demographics. She also explains how they've enhanced investigator diversity through educational sessions and multilingual toolkits, and how Takeda aims to expand these efforts globally.
--------
17:26
--------
17:26
Tariffs and Drug Prices: Understanding the Impact on Pharmaceuticals
In this Pharmaceutical Executive podcast epsiode, Peter Ax, Founder & CEO of UpScriptHealth, discusses:
The impact of tariffs on the pharmaceutical industry, highlighting branded and generics medications
How tariffs could lead to strategic supply chain changes, including potential US manufacturing shifts.
How digital health platforms, like UpScriptHealth, can help reduce friction and costs in healthcare, potentially offsetting tariff impacts
The importance of telehealth in ensuring medication availability
Strategic partnerships between digital health platforms and pharma companies to improve patient care and access
and more
--------
17:36
--------
17:36
The Misinformation Maze: Navigating Public Health in the Digital Age
In this episode of the Pharmaceutical Executive podcast, Jennifer Butler, Chief Commercial Officer of Pleio, discusses:
The threat of misinformation to public health and how emotional appeal plays a part
Where patients are turning for trustworthy health information
Strategies that can be used to verify information
Pharma's role in helping to ensure patients have access to health insights they can trust
Why the industry is turning to peer-to-patient platforms, trusted patient communities, and pharmacies to educate patients
What kind of role regulatory agencies should play in the battle against misinformation
and much more!
Check out our new look and read our February issue here: https://www.pharmexec.com/journals/pharmaceutical-executive/pharmaceutical-executive-february-2025
The Pharm Exec Podcast goes beyond the pages of the Pharmaceutical Executive print magazine and PharmExec.com to bring the latest commercial insights to the C-suite through in-depth interviews. Podcast episodes examine current trends, key conferences, and critical topics in the industry.
Sverige